直接口服抗凝剂:在临床挑战中进行导航
Maria Ioannou1, Elena Leonidou2, Ioanna Chaziri3
1Department of Cardiology, General Hospital Limassol, State Health Organization Services, 4131, Limassol, Cyprus. mar.ioannou25@gmail.com.
Cardiovascular drugs and therapy
|August 8, 2023
概括
直接口服抗凝剂 (DOAC) 对心血管有好处,但需要对伴随疾病的患者进行仔细选择. 本综述指导临床医生优化复杂病例的DOAC使用.
科学领域:
- 心脏病学 心脏病学
- 药理学 药理学是指药理学的学科.
- 内部医学 内部医学
背景情况:
- 直接口服抗凝剂 (DOACs) 已用于治疗心血管疾病已有十多年.
- 广泛的研究已经产生了复杂的数据,导致在选择多种并发症患者的最佳DOAC时面临挑战.
研究的目的:
- 为临床医生提供关于优化DOAC使用的全面审查.
- 为解决选择适合特殊人群的DOAC药物,剂量和治疗持续时间的二分歧.
主要方法:
- 进行了彻底的文献搜索和审查,重点是过去十年.
- 主要的数据库包括PubMed,科学直接Scopus和谷歌学者.
- 审查优先考虑了当前的指南和最近的出版物.
主要成果:
- DOACs是各种心血管疾病的既定治疗方法.
- 临床实践面临的挑战在DOAC选择患者的伴随性疾病.
- 需要指导,以优化复杂患者形状的DOAC治疗.
结论:
- 本综述旨在指导医疗保健专业人员在做出有关DOAC的知情决策.
- 需要进一步的研究来证实在临床不确定性的病例中DOAC的优越性.
- 优化DOAC利用对于有效的患者管理至关重要.
相关概念视频
Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants
1.2K
Oral anticoagulants are vital tools in preventing and treating blood clotting disorders. This diverse class of medications can be categorized as vitamin K antagonists, exemplified by warfarin, and direct thrombin inhibitors (DTIs), such as dabigatran, as well as factor Xa inhibitors, including rivaroxaban.
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
1.2K
Venous Thrombosis III: Interprofessional Care
10
Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
10
Anticoagulant Drugs: Low-Molecular-Weight Heparins
753
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
753
Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors
563
Antiplatelet drugs emerge as frontline defenders against the insidious threat of thromboembolic diseases, where abnormal clots obstruct vital blood vessels. These drugs stand as bulwarks, inhibiting platelet aggregation and clot formation, thereby mitigating the risk of life-threatening conditions like myocardial infarction, coronary artery disease, and thrombotic strokes.
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
563
Venous Thrombosis IV: Nursing Management
14
Nursing management begins with a thorough assessment of the patient's health history. Key factors include trauma to veins, peripherally inserted central catheters, varicose veins, recent pregnancy or childbirth, surgery, bacteremia, prolonged bed rest, atrial fibrillation, COPD, heart failure, cancer, coagulation disorders, myocardial infarction, spinal cord injury, stroke, prolonged travel, recent bone fractures, and dehydration. Review medication intake, particularly oral contraceptives,...
14
Coronary Artery Disease V: Interprofessional Care
9
Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
9


